Free Trial
→ Buy alert: Move $1,000 before Tesla’s Optimus launch (From Altimetry) (Ad)tc pixel Free CWK Stock Alerts

Cushman & Wakefield (CWK) Financials

Cushman & Wakefield logo
$17.10 +0.30 (+1.76%)
Closing price 10/24/2025 03:59 PM Eastern
Extended Trading
$17.50 +0.41 (+2.37%)
As of 10/24/2025 04:49 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare
Annual Income Statements for Cushman & Wakefield

Annual Income Statements for Cushman & Wakefield

This table shows Cushman & Wakefield's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Income / (Loss) Attributable to Common Shareholders		 -434 -221 -186 0.20 -221 250 196 -35 131
Consolidated Net Income / (Loss)		 -435 -221 -186 0.20 -221 250 196 -35 131
Net Income / (Loss) Continuing Operations		 -435 -221 -186 0.20 -221 250 196 -35 131
Total Pre-Tax Income 		-459 -342 -211 43 -177 340 338 -30 176
Total Revenue		 -166 6,742 7,993 8,603 7,688 -158 9,998 9,271 9,254
Net Interest Income / (Expense)		 -172 -183 -229 -151 -164 -180 -193 -281 -230
Total Interest Income		 0.00 0.00 0.00 0.00 0.00 0.00 -193 -281 0.00
Total Interest Expense		 172 183 229 151 164 180 0.00 0.00 230
Long-Term Debt Interest Expense		 172 183 229 151 164 180 - - 230
Total Non-Interest Income		 5.90 6,925 8,222 8,754 7,852 21 10,191 9,552 9,484
Net Realized & Unrealized Capital Gains on Investments		 5.90 1.40 1.90 2.60 8.30 21 85 58 37
Other Non-Interest Income		 - 6,924 8,220 8,751 7,844 - 10,106 9,494 9,447
Total Non-Interest Expense		 295 7,095 8,207 8,564 7,865 -497 9,660 9,301 9,108
Other Operating Expenses		 6,218 6,796 7,916 8,259 7,576 8,675 9,415 9,104 8,944
Depreciation Expense		 261 271 290 297 264 172 147 146 122
Impairment Charge		 32 29 1.50 7.70 57 45 8.90 38 41
Nonoperating Income / (Expense), net		 2.40 11 3.50 3.50 - 1.20 - - 29
Income Tax Expense		 -24 -121 -25 43 44 90 142 5.40 45
Basic Earnings per Share		 ($3.07) ($1.54) ($1.09) $0.00 ($1.00) $1.12 $0.87 ($0.16) $0.57
Weighted Average Basic Shares Outstanding		 141.40M 143.90M 171.20M 217.70M 220.80M 223M 225.40M 226.90M 228.90M
Diluted Earnings per Share		 ($3.07) ($1.54) ($1.09) $0.00 ($1.00) $1.10 $0.86 ($0.16) $0.56
Weighted Average Diluted Shares Outstanding		 141.40M 143.90M 171.20M 224.50M 220.80M 226.50M 228M 226.90M 232.80M
Weighted Average Basic & Diluted Shares Outstanding		 141.40M 143.90M 171.20M 217.70M 220.80M 224.55M 225.80M 227.33M 229.73M

Quarterly Income Statements for Cushman & Wakefield

This table shows Cushman & Wakefield's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 24 30 -76 5.10 -34 70 -29 14 34 113 1.90
Consolidated Net Income / (Loss)		 24 30 -76 5.10 -34 70 -29 14 34 113 1.90
Net Income / (Loss) Continuing Operations		 24 30 -76 5.10 -34 70 -29 14 34 113 1.90
Total Pre-Tax Income 		50 89 -89 6.40 -17 70 -27 17 53 132 5.00
Total Revenue		 -30 7,752 2,184 2,361 2,213 2,512 2,138 2,232 2,301 2,583 2,243
Net Interest Income / (Expense)		 -50 -53 -77 -58 -90 -57 -59 -61 -55 -56 -52
Total Interest Income		 0.00 -193 0.00 0.00 0.00 -281 0.00 0.00 0.00 - 0.00
Total Interest Expense		 50 -140 77 58 90 -224 59 61 55 56 52
Long-Term Debt Interest Expense		 50 - 77 58 90 - 59 61 55 56 52
Total Non-Interest Income		 20 7,805 2,261 2,419 2,303 2,569 2,197 2,292 2,356 2,639 2,296
Net Realized & Unrealized Capital Gains on Investments		 20 31 12 13 17 17 12 4.30 12 9.30 11
Other Non-Interest Income		 - - 2,249 2,406 2,286 2,552 2,185 2,288 2,344 2,630 2,285
Total Non-Interest Expense		 -112 7,753 2,274 2,355 2,228 2,444 2,164 2,214 2,248 2,481 2,239
Other Operating Expenses		 2,369 2,497 2,224 2,307 2,183 2,391 2,129 2,169 2,226 2,421 2,206
Depreciation Expense		 34 33 37 36 36 37 33 31 29 30 27
Impairment Charge		 0.60 5.80 7.20 7.00 9.20 15 5.00 17 14 4.60 6.50
Nonoperating Income / (Expense), net		 -32 - - - -2.00 - - - - - 0.90
Income Tax Expense		 26 59 -13 1.30 17 0.30 2.30 3.70 19 19 3.10
Basic Earnings per Share		 $0.11 $0.13 ($0.34) $0.02 ($0.15) $0.31 ($0.13) $0.06 $0.15 $0.49 $0.01
Weighted Average Basic Shares Outstanding		 225.70M 225.40M 226.20M 227.10M 227.20M 226.90M 227.90M 229M 229.30M 228.90M 230.40M
Diluted Earnings per Share		 $0.11 $0.12 ($0.34) $0.02 ($0.15) $0.31 ($0.13) $0.06 $0.14 $0.49 $0.01
Weighted Average Diluted Shares Outstanding		 227.50M 228M 226.20M 227.10M 227.20M 226.90M 227.90M 231.50M 233.40M 232.80M 232.30M
Weighted Average Basic & Diluted Shares Outstanding		 225.76M 225.80M 227.06M 227.15M 227.25M 227.33M 229.05M 229.25M 229.49M 229.73M 231.29M

Annual Cash Flow Statements for Cushman & Wakefield

This table details how cash moves in and out of Cushman & Wakefield's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Change in Cash & Equivalents		 -116 29 506 -95 276 -266 -151 80 36
Net Cash From Operating Activities		 -335 4.40 -2.20 269 -38 550 49 152 208
Net Cash From Continuing Operating Activities		 -335 4.40 -2.20 269 -38 550 49 152 208
Net Income / (Loss) Continuing Operations		 -435 -221 -186 0.20 -221 250 196 -35 131
Consolidated Net Income / (Loss)		 -435 -221 -186 0.20 -221 250 196 -35 131
Provision For Loan Losses		 12 3.90 24 26 48 38 32 11 21
Depreciation Expense		 261 271 290 297 264 172 147 146 122
Amortization Expense		 13 17 13 122 128 114 112 105 94
Non-Cash Adjustments to Reconcile Net Income		 38 42 138 49 -25 68 87 101 6.40
Changes in Operating Assets and Liabilities, net		 -224 -107 -280 -226 -233 -92 -524 -175 -167
Net Cash From Investing Activities		 -138 -143 -218 -275 -258 -750 -121 49 81
Net Cash From Continuing Investing Activities		 -138 -143 -218 -275 -258 -750 -121 49 81
Purchase of Property, Leasehold Improvements and Equipment		 -77 -129 -84 -80 -41 -54 -51 -51 -41
Purchase of Investment Securities		 -57 -100 -49 -280 -123 -696 -139 -0.10 -507
Divestitures		 10 - - - - - 0.00 0.00 123
Sale and/or Maturity of Investments		 3.80 86 -85 86 -94 0.20 69 100 506
Net Cash From Financing Activities		 357 168 726 -90 572 -66 -79 -121 -253
Net Cash From Continuing Financing Activities		 357 168 726 -90 572 -66 -79 -121 -253
Issuance of Debt		 640 319 2,937 0.00 650 0.00 0.00 2,400 0.00
Repayment of Debt		 -320 -164 -3,168 -39 -43 -40 -44 -2,470 -229
Other Financing Activities, Net		 -2.90 -11 -62 -51 -35 -26 -35 -51 -25

Quarterly Cash Flow Statements for Cushman & Wakefield

This table details how cash moves in and out of Cushman & Wakefield's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025
Net Change in Cash & Equivalents		 -74 212 -191 43 71 157 -209 22 197 26 -183
Net Cash From Operating Activities		 52 244 -222 -17 188 202 -125 22 196 115 -162
Net Cash From Continuing Operating Activities		 52 244 -222 -17 188 202 -125 22 196 115 -162
Net Income / (Loss) Continuing Operations		 24 30 -76 5.10 -34 70 -29 14 34 113 1.90
Consolidated Net Income / (Loss)		 24 30 -76 5.10 -34 70 -29 14 34 113 1.90
Provision For Loan Losses		 7.90 14 1.90 -0.10 3.00 5.80 2.40 5.30 3.00 10 2.80
Depreciation Expense		 34 33 37 36 36 37 33 31 29 30 27
Amortization Expense		 25 34 27 26 25 28 24 26 24 21 24
Non-Cash Adjustments to Reconcile Net Income		 30 12 29 23 23 26 -6.80 9.50 -12 16 3.90
Changes in Operating Assets and Liabilities, net		 -69 122 -240 -106 135 36 -148 -63 118 -74 -221
Net Cash From Investing Activities		 -110 -13 73 72 -65 -31 -11 68 57 -33 21
Net Cash From Continuing Investing Activities		 -110 -13 73 72 -65 -31 -11 68 57 -33 21
Purchase of Property, Leasehold Improvements and Equipment		 -14 -6.30 -10 -11 -14 -16 -11 -12 -9.40 -9.30 -4.60
Purchase of Investment Securities		 -16 -76 -6.70 -39 41 4.90 -100 100 0.40 -506 -4.80
Sale and/or Maturity of Investments		 -80 69 90 122 -92 -20 100 -20 -55 481 30
Net Cash From Financing Activities		 -16 -18 -43 -12 -52 -14 -73 -68 -57 -56 -41
Net Cash From Continuing Financing Activities		 -16 -18 -43 -12 -52 -14 -73 -68 -57 -56 -41
Repayment of Debt		 -6.70 -24 -1,024 -14 -1,431 -2.20 -62 -38 -50 -79 -25
Other Financing Activities, Net		 -9.00 5.70 -19 1.40 -21 -12 -11 -30 -7.00 23 -16

Annual Balance Sheets for Cushman & Wakefield

This table presents Cushman & Wakefield's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Total Assets		 5,793 6,546 7,163 7,338 7,890 7,949 7,774 7,549
Cash and Due from Banks		 406 895 813 1,075 771 645 768 793
Trading Account Securities		 7.90 8.70 7.90 115 641 677 708 724
Loans and Leases, Net of Allowance		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Premises and Equipment, Net		 304 314 299 236 195 173 164 136
Goodwill		 1,765 1,779 1,969 2,098 2,082 2,066 2,081 1,998
Intangible Assets		 1,306 1,128 1,063 991 922 875 806 690
Other Assets		 2,004 2,422 3,011 2,823 3,280 3,515 3,248 3,208
Total Liabilities & Shareholders' Equity		 5,793 6,546 7,163 7,338 7,890 7,949 7,774 7,549
Total Liabilities		 5,294 5,186 5,862 6,242 6,442 6,287 6,096 5,794
Short-Term Debt		 60 40 39 40 42 50 150 103
Accrued Interest Payable		 36 43 60 45 105 33 21 20
Other Short-Term Payables		 1,870 1,956 2,224 1,981 2,287 2,308 2,227 2,207
Long-Term Debt		 2,784 2,644 2,620 3,236 3,221 3,212 3,097 2,940
Other Long-Term Liabilities		 544 503 919 941 787 685 602 524
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 499 1,360 1,301 1,096 1,449 1,662 1,678 1,755
Total Preferred & Common Equity		 499 1,360 1,301 1,095 1,448 1,661 1,677 1,755
Total Common Equity		 499 1,360 1,301 1,095 1,448 1,661 1,677 1,755
Common Stock		 1,735 2,813 2,819 2,866 2,919 2,934 2,980 3,009
Retained Earnings		 -1,149 -1,298 -1,297 -1,528 -1,278 -1,082 -1,117 -986
Accumulated Other Comprehensive Income / (Loss)		 -87 -154 -243 -243 -193 -191 -185 -269
Noncontrolling Interest		 - - 0.00 0.90 0.80 0.80 0.60 0.50

Quarterly Balance Sheets for Cushman & Wakefield

This table presents Cushman & Wakefield's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025
Period end date 9/30/2022 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025
Total Assets		 7,622 7,622 7,640 7,582 7,491 7,343 7,534 7,408
Cash and Due from Banks		 381 460 502 588 554 567 775 623
Trading Account Securities		 659 686 682 694 714 711 724 735
Loans and Leases, Net of Allowance		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Premises and Equipment, Net		 156 170 166 160 155 148 142 126
Goodwill		 2,021 2,067 2,073 2,052 2,064 2,024 2,049 2,021
Intangible Assets		 885 858 841 823 791 712 703 682
Other Assets		 3,519 3,382 3,376 3,265 3,213 3,181 3,141 3,220
Total Liabilities & Shareholders' Equity		 7,622 7,622 7,640 7,582 7,491 7,343 7,534 7,408
Total Liabilities		 6,044 6,042 6,018 6,011 5,866 5,704 5,831 5,631
Short-Term Debt		 46 34 37 119 125 142 96 109
Accrued Interest Payable		 27 6.90 55 7.00 20 28 31 31
Other Short-Term Payables		 2,150 2,080 2,031 2,091 2,035 1,966 2,114 2,063
Long-Term Debt		 3,212 3,228 3,226 3,125 3,066 3,002 2,997 2,911
Other Long-Term Liabilities		 609 694 668 669 620 567 593 517
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 1,578 1,580 1,622 1,572 1,625 1,640 1,703 1,777
Total Preferred & Common Equity		 1,577 1,579 1,621 1,571 1,625 1,639 1,702 1,776
Total Common Equity		 1,577 1,579 1,621 1,571 1,625 1,639 1,702 1,776
Common Stock		 2,924 2,939 2,953 2,967 2,978 2,982 2,994 3,015
Retained Earnings		 -1,112 -1,158 -1,153 -1,187 -1,146 -1,133 -1,099 -984
Accumulated Other Comprehensive Income / (Loss)		 -235 -202 -178 -209 -207 -211 -192 -255
Noncontrolling Interest		 0.70 0.50 0.60 0.50 0.60 0.60 0.60 0.50

Annual Metrics And Ratios for Cushman & Wakefield

This table displays calculated financial ratios and metrics derived from Cushman & Wakefield's official financial filings.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Growth Metrics		 - - - - - - - - -
Revenue Growth		 0.00% 4,164.01% 18.55% 7.63% -10.63% -102.06% 6,415.60% -7.27% -0.18%
EBITDA Growth		 0.00% 65.07% 234.25% 419.61% -53.04% 190.15% -4.44% -62.98% 64.15%
EBIT Growth		 0.00% 23.52% 39.26% 118.34% -549.36% 291.79% -0.21% -108.88% 588.00%
NOPAT Growth		 0.00% 23.52% 39.26% 100.12% -67,414.69% 301.52% -21.16% -110.69% 620.68%
Net Income Growth		 0.00% 49.08% 16.04% 100.11% -110,350.00% 213.38% -21.44% -118.02% 470.90%
EPS Growth		 0.00% 49.84% 29.22% 100.00% 0.00% 210.00% -21.82% -118.60% 450.00%
Operating Cash Flow Growth		 0.00% 101.31% -150.00% 12,340.91% -114.18% 1,538.48% -91.06% 209.98% 36.66%
Free Cash Flow Firm Growth		 0.00% 0.00% 76.29% 109.81% -739.31% 82.88% 82.82% -40.13% 1,171.55%
Invested Capital Growth		 0.00% 0.00% 20.98% -2.06% 10.35% 7.79% 4.50% 0.02% -2.57%
Revenue Q/Q Growth		 0.00% 0.00% 0.00% 2.47% -4.21% -101.84% 332.69% -36.11% 0.77%
EBITDA Q/Q Growth		 0.00% 0.00% 0.00% 31.73% -8.27% 21.62% -26.91% -8.98% 5.87%
EBIT Q/Q Growth		 0.00% 0.00% 0.00% 192.69% 0.28% 59.09% -38.65% -206.12% 30.95%
NOPAT Q/Q Growth		 0.00% 0.00% 0.00% 100.62% 0.28% 223.95% -49.01% -165.49% 23.97%
Net Income Q/Q Growth		 0.00% 0.00% 0.00% 100.96% -15.99% 225.10% -37.13% 53.05% 48.87%
EPS Q/Q Growth		 0.00% 0.00% 0.00% 100.00% -16.28% 233.33% -38.13% 54.29% 47.37%
Operating Cash Flow Q/Q Growth		 0.00% 0.00% -101.06% 529.51% -125.92% 26.44% -53.06% -21.34% -29.54%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 2.60% 8.80% -131.35% -276.14% 119.50%
Invested Capital Q/Q Growth		 0.00% 0.00% 0.00% 1.57% 1.09% 4.68% 1.81% 2.26% 0.04%
Profitability Metrics		 - - - - - - - - -
EBITDA Margin		 0.00% -0.97% 1.10% 5.33% 2.80% 0.00% 5.97% 2.38% 3.92%
EBIT Margin		 0.00% -5.23% -2.68% 0.46% -2.30% 0.00% 3.38% -0.32% 1.58%
Profit (Net Income) Margin		 0.00% -3.28% -2.32% 0.00% -2.87% 0.00% 1.96% -0.38% 1.42%
Tax Burden Percent		 94.70% 64.75% 88.14% 0.47% 124.86% 73.55% 58.11% 118.00% 74.69%
Interest Burden Percent		 99.48% 96.88% 98.37% 108.91% 100.00% 100.35% 100.00% 100.00% 120.08%
Effective Tax Rate		 0.00% 0.00% 0.00% 99.53% 0.00% 26.45% 41.89% 0.00% 25.31%
Return on Invested Capital (ROIC)		 0.00% -14.78% -4.06% 0.00% -2.97% 0.00% 4.08% -0.43% 2.25%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% -12.97% -5.36% 0.01% -6.23% 0.00% 4.08% -0.87% 2.95%
Return on Net Nonoperating Assets (RNNOA)		 0.00% -73.85% -15.92% 0.01% -15.43% 0.00% 8.55% -1.69% 5.40%
Return on Equity (ROE)		 0.00% -88.63% -19.98% 0.02% -18.40% 19.65% 12.63% -2.12% 7.65%
Cash Return on Invested Capital (CROIC)		 0.00% -214.78% -23.05% 2.09% -12.81% -2.01% -0.33% -0.45% 4.85%
Operating Return on Assets (OROA)		 0.00% -6.09% -3.47% 0.57% -2.44% 0.00% 4.27% -0.38% 1.91%
Return on Assets (ROA)		 0.00% -3.82% -3.01% 0.00% -3.04% 0.00% 2.48% -0.45% 1.71%
Return on Common Equity (ROCE)		 0.00% -88.63% -19.98% 0.02% -18.39% 19.64% 12.62% -2.12% 7.65%
Return on Equity Simple (ROE_SIMPLE)		 0.00% -44.31% -13.66% 0.02% -20.14% 17.27% 11.82% -2.11% 7.48%
Net Operating Profit after Tax (NOPAT)		 -323 -247 -150 0.18 -124 249 196 -21 109
NOPAT Margin		 0.00% -3.66% -1.88% 0.00% -1.61% 0.00% 1.96% -0.23% 1.18%
Net Nonoperating Expense Percent (NNEP)		 0.00% -1.80% 1.30% 0.00% 3.26% -0.03% 0.00% 0.44% -0.70%
SG&A Expenses to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 0.00% 105.23% 102.68% 99.54% 102.30% 0.00% 96.62% 100.32% 98.42%
Earnings before Interest and Taxes (EBIT)		 -461 -353 -214 39 -177 339 338 -30 146
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -188 -66 88 458 215 624 597 221 363
Valuation Ratios		 - - - - - - - - -
Price to Book Value (P/BV)		 0.00 1.53 2.30 3.44 3.00 3.43 1.69 1.46 1.71
Price to Tangible Book Value (P/TBV)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)		 0.00 0.11 0.39 0.52 0.43 0.00 0.28 0.26 0.32
Price to Earnings (P/E)		 0.00 0.00 0.00 22,399.21 0.00 19.88 14.32 0.00 22.86
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 5.03% 6.98% 0.00% 4.37%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.96 1.22 1.60 1.26 1.58 1.10 1.00 1.09
Enterprise Value to Revenue (EV/Rev)		 0.00 0.48 0.61 0.74 0.71 0.00 0.54 0.53 0.57
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 55.73 13.80 25.50 11.95 9.10 22.34 14.48
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 160.97 0.00 22.03 16.07 0.00 35.87
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 34,448.24 0.00 29.96 27.65 0.00 48.03
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 727.93 0.00 23.49 0.00 13.58 110.61 32.42 25.25
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 75.78 0.00 0.00 0.00 0.00 22.28
Leverage & Solvency		 - - - - - - - - -
Debt to Equity		 0.00 5.69 1.97 2.04 2.99 2.25 1.96 1.93 1.73
Long-Term Debt to Equity		 0.00 5.57 1.94 2.01 2.95 2.22 1.93 1.85 1.67
Financial Leverage		 0.00 5.69 2.97 2.01 2.48 2.57 2.10 1.95 1.83
Leverage Ratio		 0.00 11.60 6.64 5.15 6.05 5.99 5.09 4.71 4.46
Compound Leverage Factor		 0.00 11.24 6.53 5.61 6.05 6.01 5.09 4.71 5.36
Debt to Total Capital		 0.00% 85.06% 66.37% 67.15% 74.93% 69.25% 66.24% 65.93% 63.42%
Short-Term Debt to Total Capital		 0.00% 1.78% 0.99% 0.99% 0.91% 0.90% 1.01% 3.04% 2.15%
Long-Term Debt to Total Capital		 0.00% 83.28% 65.38% 66.15% 74.03% 68.35% 65.23% 62.89% 61.26%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.02% 0.02% 0.02% 0.01% 0.01%
Common Equity to Total Capital		 0.00% 14.94% 33.63% 32.85% 25.04% 30.73% 33.74% 34.06% 36.57%
Debt to EBITDA		 0.00 -43.28 30.43 5.80 15.22 5.23 5.47 14.70 8.39
Net Debt to EBITDA		 0.00 -37.11 20.28 4.03 10.23 3.99 4.39 11.22 6.20
Long-Term Debt to EBITDA		 0.00 -42.37 29.98 5.72 15.04 5.16 5.38 14.02 8.11
Debt to NOPAT		 0.00 -11.51 -17.89 14,482.30 -26.50 13.10 16.61 -154.60 27.83
Net Debt to NOPAT		 0.00 -9.87 -11.92 10,054.19 -17.80 10.00 13.32 -118.04 20.57
Long-Term Debt to NOPAT		 0.00 -11.27 -17.63 14,268.30 -26.17 12.93 16.35 -147.47 26.88
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.04% 0.07% 0.05% 0.04% 0.03%
Liquidity Ratios		 - - - - - - - - -
Cash Flow Metrics		 - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 0.00 -3,590 -851 83 -534 -91 -16 -22 236
Operating Cash Flow to CapEx		 -433.51% 3.41% -2.61% 335.37% -93.17% 1,021.38% 96.84% 298.43% 507.32%
Free Cash Flow to Firm to Interest Expense		 0.00 -19.61 -3.72 0.55 -3.26 -0.51 0.00 0.00 1.03
Operating Cash Flow to Interest Expense		 -1.95 0.02 -0.01 1.79 -0.23 3.06 0.00 0.00 0.90
Operating Cash Flow Less CapEx to Interest Expense		 -2.40 -0.68 -0.38 1.26 -0.48 2.76 0.00 0.00 0.73
Efficiency Ratios		 - - - - - - - - -
Asset Turnover		 0.00 1.16 1.30 1.26 1.06 0.00 1.26 1.18 1.21
Fixed Asset Turnover		 0.00 22.16 25.86 28.06 28.72 0.00 54.45 55.12 61.73
Capital & Investment Metrics		 - - - - - - - - -
Invested Capital		 0.00 3,343 4,044 3,961 4,371 4,712 4,924 4,925 4,798
Invested Capital Turnover		 0.00 4.03 2.16 2.15 1.85 0.00 2.08 1.88 1.90
Increase / (Decrease) in Invested Capital		 0.00 3,343 701 -83 410 341 212 1.00 -126
Enterprise Value (EV)		 0.00 3,203 4,915 6,326 5,488 7,463 5,431 4,934 5,252
Market Capitalization		 765 765 3,126 4,480 3,287 4,970 2,813 2,454 3,002
Book Value per Share		 $0.00 $3.47 $6.30 $5.94 $4.94 $6.48 $7.36 $7.38 $7.65
Tangible Book Value per Share		 $0.00 ($17.87) ($7.16) ($7.90) ($9.00) ($6.96) ($5.66) ($5.32) ($4.07)
Total Capital		 0.00 3,343 4,044 3,961 4,371 4,712 4,924 4,925 4,798
Total Debt		 0.00 2,844 2,684 2,660 3,275 3,263 3,262 3,247 3,043
Total Long-Term Debt		 0.00 2,784 2,644 2,620 3,236 3,221 3,212 3,097 2,940
Net Debt		 0.00 2,438 1,789 1,846 2,201 2,492 2,617 2,479 2,250
Capital Expenditures (CapEx)		 77 129 84 80 41 54 51 51 41
Net Nonoperating Expense (NNE)		 112 -26 36 -0.02 97 -0.88 0.00 14 -22
Net Nonoperating Obligations (NNO)		 0.00 2,844 2,684 2,660 3,275 3,263 3,262 3,247 3,043
Total Depreciation and Amortization (D&A)		 273 287 303 419 392 286 259 251 216
Earnings Adjustments		 - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.00 $0.00 ($1.09) $0.00 ($1.00) $1.12 $0.87 ($0.16) $0.57
Adjusted Weighted Average Basic Shares Outstanding		 0.00 0.00 216.60M 219.89M 222.18M 223M 225.40M 226.90M 228.90M
Adjusted Diluted Earnings per Share		 $0.00 $0.00 ($1.09) $0.00 ($1.00) $1.10 $0.86 ($0.16) $0.56
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 0.00 216.60M 224.50M 220.80M 226.50M 228M 226.90M 232.80M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 ($1.09) $0.00 ($1.00) $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 0.00 171.20M 217.70M 220.80M 224.55M 225.80M 227.33M 229.73M
Normalized Net Operating Profit after Tax (NOPAT)		 -4,651 -227 -149 33 -106 -6,624 253 14 140
Normalized NOPAT Margin		 0.00% -3.37% -1.86% 0.38% -1.38% 0.00% 2.53% 0.16% 1.51%
Pre Tax Income Margin		 0.00% -5.07% -2.64% 0.50% -2.30% 0.00% 3.38% -0.32% 1.90%
Debt Service Ratios		 - - - - - - - - -
EBIT to Interest Expense		 -2.69 -1.93 -0.94 0.26 -1.08 1.89 0.00 0.00 0.64
NOPAT to Interest Expense		 -1.88 -1.35 -0.66 0.00 -0.75 1.39 0.00 0.00 0.48
EBIT Less CapEx to Interest Expense		 -3.14 -2.63 -1.30 -0.27 -1.33 1.59 0.00 0.00 0.46
NOPAT Less CapEx to Interest Expense		 -2.33 -2.05 -1.02 -0.53 -1.01 1.09 0.00 0.00 0.30
Payout Ratios		 - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Quarterly Metrics And Ratios for Cushman & Wakefield

This table displays calculated financial ratios and metrics derived from Cushman & Wakefield's official financial filings.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 -101.33% 218.49% -5.22% 8,354.90% 7,379.93% -67.59% -2.13% -5.48% 3.99% 2.83% 4.94%
EBITDA Growth		 -11.75% -77.01% -114.46% -68.24% -67.33% 102.44% 215.23% 9.14% 131.37% 15.14% 96.04%
EBIT Growth		 -7.05% -100.33% -181.83% -95.68% -118.73% 9,828.57% 70.29% 168.75% 446.41% 50.81% 114.54%
NOPAT Growth		 -40.88% -80.97% -195.81% -95.64% -127.48% 134.23% 70.29% 164.71% 414.66% 61.75% 107.89%
Net Income Growth		 -65.21% -79.56% -267.91% -94.75% -241.84% 134.23% 62.30% 164.71% 199.41% 61.75% 106.60%
EPS Growth		 -63.33% -81.54% -270.00% -95.35% -236.36% 158.33% 61.76% 200.00% 193.33% 58.06% 107.69%
Operating Cash Flow Growth		 -68.36% -18.55% -40.01% 80.93% 263.83% -16.95% 43.52% 229.76% 4.25% -43.08% -29.50%
Free Cash Flow Firm Growth		 -166.36% 0.88% 70.18% 87.44% 103.27% 137.74% 105.99% 413.55% 445.92% 247.82% 325.54%
Invested Capital Growth		 7.45% 4.50% 0.91% 0.87% -0.42% 0.02% -0.51% -2.09% -0.40% -2.57% -0.42%
Revenue Q/Q Growth		 -6.29% 25,599.67% -71.82% 8.08% -6.26% 13.52% -55.45% 4.38% 3.13% 12.25% -13.16%
EBITDA Q/Q Growth		 -34.19% -53.31% -116.56% 364.84% -32.30% 189.32% -77.79% 150.85% 43.51% 43.97% -64.36%
EBIT Q/Q Growth		 -44.80% -100.86% -201.02% 107.17% -339.06% 545.10% -138.91% 164.91% 208.14% 93.77% -96.01%
NOPAT Q/Q Growth		 -66.68% -23.54% -310.72% 108.17% -310.00% 751.73% -126.58% 172.78% 149.63% 235.01% -98.62%
Net Income Q/Q Growth		 -75.41% 24.69% -356.38% 106.68% -764.71% 305.90% -141.26% 146.88% 149.63% 235.01% -98.32%
EPS Q/Q Growth		 -74.42% 9.09% -383.33% 105.88% -850.00% 306.67% -141.94% 146.15% 133.33% 250.00% -97.96%
Operating Cash Flow Q/Q Growth		 158.68% 371.37% -190.89% 92.42% 1,219.64% 7.60% -161.81% 117.43% 799.54% -41.25% -240.63%
Free Cash Flow Firm Q/Q Growth		 -0.81% 38.44% 41.94% 65.17% 126.26% 610.01% -90.77% 1,722.05% -54.28% 352.36% -90.82%
Invested Capital Q/Q Growth		 -0.15% 1.81% -1.67% 0.91% -1.42% 2.26% -2.20% -0.69% 0.28% 0.04% -0.05%
Profitability Metrics		 - - - - - - - - - - -
EBITDA Margin		 0.00% 0.85% -1.17% 2.87% 2.07% 5.29% 1.38% 3.32% 4.61% 5.92% 2.43%
EBIT Margin		 0.00% -0.01% -4.08% 0.27% -0.69% 2.71% -1.24% 0.77% 2.30% 3.98% 0.18%
Profit (Net Income) Margin		 0.00% 0.38% -3.50% 0.22% -1.53% 2.78% -1.35% 0.61% 1.46% 4.37% 0.08%
Tax Burden Percent		 47.70% 33.56% 85.65% 79.69% 195.95% 99.57% 108.68% 78.49% 63.58% 85.47% 38.00%
Interest Burden Percent		 61.32% -12,685.71% 100.00% 100.00% 113.07% 102.94% 100.00% 100.00% 100.00% 128.63% 121.95%
Effective Tax Rate		 52.30% 66.44% 0.00% 20.31% 0.00% 0.43% 0.00% 21.51% 36.42% 14.53% 62.00%
Return on Invested Capital (ROIC)		 0.00% 0.80% -5.86% 0.54% -1.46% 5.23% -1.66% 1.14% 2.80% 8.32% 0.14%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 0.80% -6.29% 0.54% -2.17% 5.23% -1.98% 1.14% 2.80% 8.32% 0.15%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 1.67% -13.15% 1.11% -4.48% 10.19% -3.98% 2.24% 5.42% 15.24% 0.27%
Return on Equity (ROE)		 22.20% 2.47% -19.01% 1.65% -5.93% 15.42% -5.63% 3.37% 8.21% 23.56% 0.40%
Cash Return on Invested Capital (CROIC)		 1.07% -0.33% 0.64% -1.23% 0.26% -0.45% 0.77% 2.54% 2.23% 4.85% 3.33%
Operating Return on Assets (OROA)		 0.00% -0.01% -5.25% 0.43% -1.32% 3.20% -1.51% 0.94% 2.80% 4.80% 0.23%
Return on Assets (ROA)		 0.00% 0.49% -4.49% 0.34% -2.92% 3.28% -1.64% 0.73% 1.78% 5.28% 0.11%
Return on Common Equity (ROCE)		 22.19% 2.47% -19.00% 1.65% -5.93% 15.42% -5.63% 3.37% 8.21% 23.55% 0.40%
Return on Equity Simple (ROE_SIMPLE)		 19.80% 0.00% 4.72% -1.09% -4.80% 0.00% 0.75% 1.26% 5.18% 0.00% 9.12%
Net Operating Profit after Tax (NOPAT)		 39 30 -62 5.10 -11 70 -19 14 34 113 1.56
NOPAT Margin		 0.00% 0.38% -2.86% 0.22% -0.48% 2.78% -0.87% 0.61% 1.46% 4.37% 0.07%
Net Nonoperating Expense Percent (NNEP)		 0.46% 0.00% 0.43% 0.00% 0.71% 0.00% 0.32% 0.00% 0.00% 0.00% -0.01%
SG&A Expenses to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 0.00% 100.01% 104.08% 99.73% 100.69% 97.29% 101.24% 99.23% 97.70% 96.02% 99.82%
Earnings before Interest and Taxes (EBIT)		 82 -0.70 -89 6.40 -15 68 -27 17 53 103 4.10
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 141 66 -26 68 46 133 30 74 106 153 55
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 1.64 1.69 1.51 1.15 1.10 1.46 1.46 1.45 1.84 1.71 1.32
Price to Tangible Book Value (P/TBV)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)		 0.00 0.28 0.24 0.15 0.12 0.26 0.26 0.26 0.34 0.32 0.25
Price to Earnings (P/E)		 8.27 14.32 31.95 0.00 0.00 0.00 194.84 115.64 35.43 22.86 14.49
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 12.09% 6.98% 3.13% 0.00% 0.00% 0.00% 0.51% 0.86% 2.82% 4.37% 6.90%
Enterprise Value to Invested Capital (EV/IC)		 1.13 1.10 1.07 0.95 0.91 1.00 1.04 1.04 1.13 1.09 0.99
Enterprise Value to Revenue (EV/Rev)		 0.00 0.54 0.52 0.38 0.30 0.53 0.54 0.55 0.59 0.57 0.51
Enterprise Value to EBITDA (EV/EBITDA)		 6.69 9.10 10.73 13.69 18.08 22.34 18.17 17.57 15.89 14.48 12.19
Enterprise Value to EBIT (EV/EBIT)		 9.91 16.07 22.65 52.97 0.00 0.00 153.37 114.00 48.69 35.87 26.55
Enterprise Value to NOPAT (EV/NOPAT)		 14.18 27.65 69.56 0.00 0.00 0.00 411.07 240.72 61.72 48.03 33.97
Enterprise Value to Operating Cash Flow (EV/OCF)		 52.22 110.61 0.00 80.89 22.67 32.42 20.17 17.27 18.44 25.25 27.73
Enterprise Value to Free Cash Flow (EV/FCFF)		 109.05 0.00 167.18 0.00 351.26 0.00 135.18 40.38 50.68 22.28 29.64
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 2.06 1.96 2.07 2.01 2.06 1.93 1.96 1.92 1.82 1.73 1.70
Long-Term Debt to Equity		 2.04 1.93 2.04 1.99 1.99 1.85 1.89 1.83 1.76 1.67 1.64
Financial Leverage		 2.32 2.10 2.09 2.03 2.06 1.95 2.01 1.96 1.94 1.83 1.83
Leverage Ratio		 5.36 5.09 4.93 4.79 4.83 4.71 4.72 4.59 4.62 4.46 4.38
Compound Leverage Factor		 3.29 -645.96 4.93 4.79 5.46 4.85 4.72 4.59 4.62 5.74 5.34
Debt to Total Capital		 67.37% 66.24% 67.37% 66.80% 67.37% 65.93% 66.25% 65.72% 64.49% 63.42% 62.95%
Short-Term Debt to Total Capital		 0.96% 1.01% 0.70% 0.75% 2.47% 3.04% 2.60% 2.96% 2.01% 2.15% 2.26%
Long-Term Debt to Total Capital		 66.41% 65.23% 66.68% 66.05% 64.90% 62.89% 63.66% 62.76% 62.48% 61.26% 60.69%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.01% 0.02% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01%
Common Equity to Total Capital		 32.62% 33.74% 32.62% 33.19% 32.62% 34.06% 33.74% 34.27% 35.49% 36.57% 37.04%
Debt to EBITDA		 3.99 5.47 6.75 9.67 13.37 14.70 11.56 11.14 9.03 8.39 7.75
Net Debt to EBITDA		 3.52 4.39 5.80 8.19 10.94 11.22 9.56 9.13 6.77 6.20 6.15
Long-Term Debt to EBITDA		 3.93 5.38 6.68 9.57 12.88 14.02 11.11 10.64 8.75 8.11 7.48
Debt to NOPAT		 8.46 16.61 43.78 -185.40 -410.13 -154.60 261.55 152.59 35.07 27.83 21.62
Net Debt to NOPAT		 7.47 13.32 37.61 -156.86 -335.76 -118.04 216.18 125.05 26.28 20.57 17.16
Long-Term Debt to NOPAT		 8.34 16.35 43.33 -183.32 -395.09 -147.47 251.30 145.71 33.98 26.88 20.84
Noncontrolling Interest Sharing Ratio		 0.05% 0.05% 0.04% 0.04% 0.04% 0.04% 0.03% 0.04% 0.03% 0.03% 0.03%
Liquidity Ratios		 - - - - - - - - - - -
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -296 -182 -106 -37 9.69 69 6.35 116 53 239 22
Operating Cash Flow to CapEx		 371.94% 3,868.25% -2,215.00% -158.49% 1,324.65% 1,249.38% -1,191.43% 184.75% 2,086.17% 1,238.71% -3,521.74%
Free Cash Flow to Firm to Interest Expense		 -5.88 0.00 -1.38 -0.64 0.11 0.00 0.11 1.90 0.96 4.31 0.42
Operating Cash Flow to Interest Expense		 1.03 0.00 -2.88 -0.29 2.10 0.00 -2.13 0.36 3.57 2.08 -3.10
Operating Cash Flow Less CapEx to Interest Expense		 0.75 0.00 -3.01 -0.47 1.94 0.00 -2.31 0.16 3.40 1.91 -3.19
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.00 1.26 1.28 1.60 1.91 1.18 1.22 1.21 1.22 1.21 1.26
Fixed Asset Turnover		 0.00 54.45 54.56 70.78 91.72 55.12 56.80 57.89 60.83 61.73 66.59
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 4,836 4,924 4,841 4,885 4,816 4,925 4,816 4,783 4,796 4,798 4,796
Invested Capital Turnover		 0.00 2.08 2.05 2.52 3.01 1.88 1.91 1.88 1.91 1.90 1.95
Increase / (Decrease) in Invested Capital		 335 212 44 42 -20 1.00 -25 -102 -19 -126 -20
Enterprise Value (EV)		 5,462 5,431 5,183 4,619 4,387 4,934 5,015 4,959 5,443 5,252 4,744
Market Capitalization		 2,584 2,813 2,380 1,857 1,731 2,454 2,377 2,382 3,125 3,002 2,348
Book Value per Share		 $6.99 $7.36 $6.99 $7.14 $6.92 $7.38 $7.13 $7.16 $7.43 $7.65 $7.73
Tangible Book Value per Share		 ($5.89) ($5.66) ($5.96) ($5.69) ($5.74) ($5.32) ($5.40) ($4.79) ($4.58) ($4.07) ($4.03)
Total Capital		 4,836 4,924 4,841 4,885 4,816 4,925 4,816 4,783 4,796 4,798 4,796
Total Debt		 3,258 3,262 3,262 3,263 3,244 3,247 3,191 3,143 3,093 3,043 3,019
Total Long-Term Debt		 3,212 3,212 3,228 3,226 3,125 3,097 3,066 3,002 2,997 2,940 2,911
Net Debt		 2,877 2,617 2,802 2,761 2,656 2,479 2,637 2,576 2,318 2,250 2,396
Capital Expenditures (CapEx)		 14 6.30 10 11 14 16 11 12 9.40 9.30 4.60
Net Nonoperating Expense (NNE)		 15 0.00 14 0.00 23 0.00 10 0.00 0.00 0.00 -0.34
Net Nonoperating Obligations (NNO)		 3,258 3,262 3,262 3,263 3,244 3,247 3,191 3,143 3,093 3,043 3,019
Total Depreciation and Amortization (D&A)		 59 66 64 61 61 65 56 57 53 50 50
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.11 $0.13 ($0.34) $0.02 ($0.15) $0.31 ($0.13) $0.06 $0.15 $0.49 $0.01
Adjusted Weighted Average Basic Shares Outstanding		 225.70M 225.40M 226.20M 227.10M 227.20M 226.90M 227.90M 229M 229.30M 228.90M 230.40M
Adjusted Diluted Earnings per Share		 $0.11 $0.12 ($0.34) $0.02 ($0.15) $0.31 ($0.13) $0.06 $0.14 $0.49 $0.01
Adjusted Weighted Average Diluted Shares Outstanding		 227.50M 228M 226.20M 227.10M 227.20M 226.90M 227.90M 231.50M 233.40M 232.80M 232.30M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 225.76M 225.80M 227.06M 227.15M 227.25M 227.33M 229.05M 229.25M 229.49M 229.73M 231.29M
Normalized Net Operating Profit after Tax (NOPAT)		 -1,703 66 -53 15 -4.27 84 -16 25 30 117 7.42
Normalized NOPAT Margin		 0.00% 0.85% -2.44% 0.61% -0.19% 3.36% -0.76% 1.10% 1.28% 4.52% 0.33%
Pre Tax Income Margin		 0.00% 1.15% -4.08% 0.27% -0.78% 2.79% -1.24% 0.77% 2.30% 5.11% 0.22%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 1.62 0.00 -1.16 0.11 -0.17 0.00 -0.45 0.28 0.97 1.85 0.08
NOPAT to Interest Expense		 0.77 0.00 -0.81 0.09 -0.12 0.00 -0.32 0.22 0.61 2.03 0.03
EBIT Less CapEx to Interest Expense		 1.35 0.00 -1.29 -0.07 -0.33 0.00 -0.63 0.09 0.79 1.68 -0.01
NOPAT Less CapEx to Interest Expense		 0.50 0.00 -0.94 -0.10 -0.28 0.00 -0.49 0.03 0.44 1.87 -0.06
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

Financial Performance and Profitability:

  • Cushman & Wakefield showed clear improvement in Q4 2024 with net income of $112.9 million after posting losses in earlier quarters of 2024 and 2023, signaling a possible turnaround.
  • The company has experienced significant quarterly net losses in early 2023 and Q1 2024, including a Q1 2024 net loss of $28.8 million.
  • Interest expense is substantial, with long-term debt interest expense consistently around $52 million to $89 million per quarter, contributing to a negative net interest income.
  • Earnings per share have been volatile, from a loss of $0.34 in Q1 2023 to a profit of $0.49 in Q4 2024, showing inconsistency in shareholder returns.

Revenue and Expenses Trends:

  • Total revenue has generally increased over the analyzed periods, with Q1 2025 showing $2.24 billion in revenue, slightly down from Q4 2024's $2.58 billion but higher than most quarters in 2023.
  • Operating expenses remain high, with non-interest expenses close to $2.2 billion in Q1 2025, creating tight net income margins.
  • The company has consistent depreciation and amortization expenses of about $25 million to $37 million per quarter, reflecting ongoing capital usage but also potential tax benefits and asset base maintenance.

Cash Flow and Liquidity:

  • Operating cash flow has been negative in some recent quarters (Q1 2025: -$162 million), indicating cash burn from core operations.
  • Investing cash flow has been positive in Q1 2025 ($20.6 million) due to sales/maturities of investments outpacing purchases, which may support liquidity.
  • Financing cash flow has been negative consistently, with significant repayments of debt (Q1 2025: -$25 million) and other financing outflows, indicating debt reduction but potential pressure on cash reserves.
  • Cash and equivalents remain substantial, at $623 million as of Q1 2025, supporting liquidity despite negative operating cash flow.

Balance Sheet and Capital Structure:

  • Long-term debt remains very high at approximately $2.9 billion in Q1 2025, with total liabilities over $5.6 billion, indicating a leveraged balance sheet.
  • Total assets have slightly decreased to about $7.4 billion by Q1 2025 from $7.6-$7.8 billion in prior quarters, showing stability but little growth.
  • Retained earnings are negative (-$984 million in Q1 2025), reflecting accumulated deficits over time that may constrain growth and dividends.
  • Total equity stands at about $1.77 billion in Q1 2025, maintaining a modest equity cushion relative to liabilities but underscoring reliance on debt financing.

Summary:

Cushman & Wakefield has faced ongoing challenges with profitability and cash flow across 2023 and early 2024 but showed signs of improvement late in 2024. Revenues have stabilized around $2.2 to $2.6 billion per quarter, though high operating costs and substantial interest expenses weigh heavily on net income. The company carries significant debt, which results in elevated interest expenses and financial leverage. Liquidity appears adequate with considerable cash balances and some positive investing cash flow, but negative operating cash flow in recent quarters is a concern. Negative retained earnings highlight past accumulated losses, signaling a need for sustained profitability to rebuild shareholder equity. Overall, investors should watch for continued improvements in earnings and cash flow alongside efforts to manage the debt burden.

10/25/25 06:17 AM ETAI Generated. May Contain Errors.

Frequently Asked Questions About Cushman & Wakefield's Financials

When does Cushman & Wakefield's fiscal year end?

According to the most recent income statement we have on file, Cushman & Wakefield's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Cushman & Wakefield's net income changed over the last 8 years?

Cushman & Wakefield's net income appears to be on a downward trend, with a most recent value of $131.30 million in 2024, falling from -$434.60 million in 2016. The previous period was -$35.40 million in 2023. Find out what analysts predict for Cushman & Wakefield in the coming months.

How has Cushman & Wakefield's revenue changed over the last 8 years?

Over the last 8 years, Cushman & Wakefield's total revenue changed from -$165.90 million in 2016 to $9.25 billion in 2024, a change of -5,678.1%.

How much debt does Cushman & Wakefield have?

Cushman & Wakefield's total liabilities were at $5.79 billion at the end of 2024, a 5.0% decrease from 2023, and a 9.4% increase since 2017.

How much cash does Cushman & Wakefield have?

In the past 7 years, Cushman & Wakefield's cash and equivalents has ranged from $405.60 million in 2017 to $1.07 billion in 2020, and is currently $793.30 million as of their latest financial filing in 2024.

How has Cushman & Wakefield's book value per share changed over the last 8 years?

Over the last 8 years, Cushman & Wakefield's book value per share changed from 0.00 in 2016 to 7.65 in 2024, a change of 764.7%.


Related Companies

This page (NYSE:CWK) was last updated on 10/25/2025 by MarketBeat.com Staff
From Our Partners
NEW LAW: Congress Approves Setup For Digital Dollar?
Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...
Goldco Precious Metals | Sponsoredtc pixel
If You Keep Cash In A U.S. Bank Account… Read This NOW
The Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...
Banyan Hill Publishing | Sponsoredtc pixel
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Traders Agency | Sponsoredtc pixel
$100 Trillion “AI Metal” Found in American Ghost Town
Jeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...
Brownstone Research | Sponsoredtc pixel
“Fed Proof” Your Bank Account with THESE 4 Simple Steps
Starting as soon as a few months from now, the United States government will make a sweeping change to bank ac...
Weiss Ratings | Sponsoredtc pixel
Move $1,000 into this stock before Nov 6
The End of Tesla? "Hold onto your Tesla stock." That's the message insiders at Tesla have been giving staff...
Altimetry | Sponsoredtc pixel
Buy UBER immediately
BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...
Chaikin Analytics | Sponsoredtc pixel
Front-Run Buffett's Shocking Gold Move
A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...
Golden Portfolio | Sponsoredtc pixel